PRGO - Perrigo Company plc
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $0.80
|
Rev Est: $1.1B
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$21.50
DETAILS
HIGH:
$23.00
LOW:
$20.00
MEDIAN:
$21.50
CONSENSUS:
$21.50
UPSIDE:
47.16%
Market Cap:
2.01B
Volume:
1,505,509
Avg Volume:
3,317,396
52 Week Range:
12.17-30.93
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
0.40
Last Dividend:
$1.16
Exchange:
NYSE
Country:
IE
Employees:
8,379
IPO Date:
1991-12-17
EPS (TTM):
-1.25
P/E Ratio:
-20.56
Revenue (TTM):
4.37B
Total Assets:
9.65B
Total Debt:
3.62B
Cash & Equiv:
558.80M
Rev Growth (5Y):
2.5%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
-0.4%
ROCE:
1.2%
Debt/Equity:
0.84
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $0.80 | $0.75 | +6.7% | $1.0B | $1.1B | -4.5% |
| 2025-08-06 | $0.57 | $0.59 | -3.4% | $1.1B | $1.1B | -4.0% |
| 2025-05-07 | $0.60 | $0.56 | +7.1% | $1.0B | $1.1B | -3.0% |
| 2025-02-27 | $0.93 | $0.92 | +1.1% | $1.1B | $1.1B | +4.4% |
| 2024-11-06 | $0.81 | $0.82 | -1.2% | $1.1B | $1.2B | -9.2% |
| 2024-08-02 | $0.53 | $0.48 | +10.4% | $1.1B | $1.1B | -5.7% |
| 2024-05-07 | $0.29 | $0.24 | +20.8% | $1.1B | $1.1B | -1.1% |
| 2024-02-27 | $0.86 | $0.83 | +3.6% | $1.2B | $1.2B | -1.6% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.37B | 4.66B | 4.45B | 4.14B | 4.09B | 3.87B | 4.73B | 4.95B | 5.28B | 4.60B | 4.06B | 3.54B |
| Net Income | (171.80M) | (12.70M) | (140.60M) | (68.90M) | (162.60M) | 146.10M | 131.00M | 119.60M | (4.01B) | 127.90M | 205.30M | 441.90M |
| EPS | -1.25 | -0.09 | -0.97 | -0.98 | -1.19 | 1.07 | 0.95 | 0.84 | -28.01 | 0.92 | 1.78 | 4.71 |
| Total Assets | 9.65B | 10.81B | 11.02B | 10.43B | 11.49B | 11.30B | 10.98B | 11.63B | 13.87B | 19.39B | 13.88B | 5.35B |
| Total Debt | 3.62B | 4.07B | 4.32B | 3.69B | 3.73B | 3.37B | 3.24B | 3.34B | 5.80B | 5.99B | 3.23B | 1.97B |
| Cash & Equivalents | 558.80M | 751.30M | 600.70M | 1.86B | 631.50M | 354.30M | 551.10M | 678.70M | 622.30M | 417.80M | 799.50M | 779.90M |
| Operating Cash Flow | 362.90M | 405.50M | 307.30M | 156.30M | 636.20M | 387.80M | 593.00M | 698.90M | 654.90M | 1.20B | 693.50M | 553.80M |
| Free Cash Flow | 244.60M | 303.80M | 210.90M | 4.20M | 465.80M | 250.10M | 490.40M | 610.30M | 548.70M | 1.06B | 521.90M | 449.70M |
| FCF per Share | 1.78 | 2.25 | 1.57 | 0.03 | 3.42 | 1.84 | 3.56 | 4.29 | 3.83 | 7.62 | 4.53 | 4.79 |
| Book Value | 4.32B | 4.77B | 4.84B | 5.15B | 5.66B | 5.80B | 5.67B | 6.17B | 5.96B | 10.04B | 8.69B | 2.33B |
| Cash & ST Investments | 558.80M | 751.30M | 600.70M | 1.86B | 631.50M | 354.30M | 551.10M | 678.70M | 622.30M | 417.80M | 805.40M | 779.90M |
| ROC Equity | -0.04 | -0.00 | -0.03 | -0.01 | -0.03 | 0.03 | 0.02 | 0.02 | -0.67 | 0.01 | 0.02 | 0.19 |